Led by Boston Scientific, the funding will expedite the clinical development and commercialisation of 4C Medical’s transcatheter mitral valve replacement (TMVR) technology, AltaValve System. Piper ...
4C Medical Technologies Inc. raised $175 million in a series D financing round led by Boston Scientific Corp. The financing will support the regulatory trials and commercialization of the Altavalve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback